Central Asia vs Cyprus: Proportion of the target population who received the final dose of
Central Asia
59.0%
in 2024
Cyprus
89.0%
in 2024
Central Asia rank
8th
Cyprus rank
11th
Proportion of the target population who received the final dose of over time
- Central Asia
- Cyprus
How they compare
Cyprus currently reports 89.0% against 59.0% in Central Asia, a difference of 30.0%.
That makes Cyprus's figure about 1.5 times Central Asia's.
Across all 7 years both countries report, Cyprus has been ahead every year.
Central Asia ranks 8th and Cyprus ranks 11th of 35 groups.
Cyprus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central Asia | Cyprus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.0% | 61.7% | 53.7% | Cyprus |
| 2020s | 52.5% | 84.5% | 32.0% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Central Asia or Cyprus?
- Cyprus, at 89.0% against 59.0% in Central Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Central Asia and Cyprus?
- 30.0%, with Cyprus ahead.
- How many years of comparable data are there for Central Asia and Cyprus?
- 7 years are reported by both, from 2017 to 2024.
- How do Central Asia and Cyprus rank globally for proportion of the target population who received the final dose of?
- Central Asia ranks 8th and Cyprus ranks 11th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.